Metabolomic biomarkers in blood samples identify cancers in a mixed population of patients with nonspecific symptoms
<strong>Purpose:</strong> Early diagnosis of cancer is critical for improving patient outcomes, but cancers may be hard to diagnose if patients present with nonspecific signs and symptoms. We have previously shown that nuclear magnetic resonance (NMR) metabolomics analysis can detect can...
Главные авторы: | Larkin, JR, Anthony, S, Johanssen, VA, Yeo, T, Sealey, M, Yates, AG, Smith, CF, Claridge, TDW, Nicholson, BD, Moreland, J-A, Gleeson, F, Sibson, NR, Anthony, DC, Probert, F |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
American Association for Cancer Research
2022
|
Схожие документы
-
Early diagnosis of brain metastases through biofluid metabolomics
по: Larkin, JR, и др.
Опубликовано: (2017) -
Classifying the antibody-negative NMO syndromes: Clinical, imaging, and metabolomic modeling
по: Yeo, T, и др.
Опубликовано: (2019) -
Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosis
по: Probert, F, и др.
Опубликовано: (2021) -
A blood-based metabolomics test to distinguish relapsing–remitting and secondary progressive multiple sclerosis: addressing practical considerations for clinical application
по: Yeo, T, и др.
Опубликовано: (2020) -
Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model
по: Yeo, T, и др.
Опубликовано: (2022)